Nomura Holdings Inc Bio N Tech Se Transaction History

Nomura Holdings Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$80.36 - $102.87 $337,512 - $432,054	4,200 New	4,200 $337,000
Q2 2022 Aug 15, 2022	BUY	$123.25 - $186.24 $307,508 - $464,668	2,495 Added 39.75%	8,772 $1.25 Million
Q1 2022 May 18, 2022	BUY	$126.25 - $231.85 $258,307 - $474,365	2,046 Added 48.36%	6,277 $1.1 Million
Q4 2021 Feb 14, 2022	SELL	$216.64 - $362.52 $228,338 - $382,096	-1,054 Reduced 19.94%	4,231 $1.09 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $1.09 Million - $2.36 Million	5,285 New	5,285 $1.47 Million
Q4 2020 Feb 16, 2021	SELL	$72.71 - $129.54 $421,717 - $751,332	-5,800 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$57.81 - $104.17 $335,298 - $604,186	5,800 New	5,800 $401,000

356

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.